Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart J D Neil

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
Biorxiv : the Preprint Server for Biology|February 10, 2021
Impact of the B.1.1.7 variant on neutralizing monoclonal antibodies recognizing diverse epitopes on SARS-CoV-2 SpikeCarl Graham, Jeffrey Seow, Isabella Huettner, et al.
Immunity|April 9, 2021
Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variantCarl Graham, Jeffrey Seow, Isabella Huettner, et al.
Plos Pathogens|September 24, 2020
Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settingsSuzanne Pickering, Gilberto Betancor, Rui Pedro Galão, et al.
The Journal of Infection|October 17, 2020
Estimates of the rate of infection and asymptomatic COVID-19 disease in a population sample from SE EnglandPhilippa M Wells, Katie J Doores, Simon Couvreur, et al.
Biology Methods & Protocols|July 12, 2024
KCL TEST: an open-source inspired asymptomatic SARS-CoV-2 surveillance programme in an academic institutionJoana Reis de Andrade, Edward Scourfield, Shilpa Lekhraj Peswani-Sajnani, et al.
Nature Microbiology|October 27, 2020
Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humansJeffrey Seow, Carl Graham, Blair Merrick, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Biorxiv : the Preprint Server for Biology|February 10, 2021
Impact of the B.1.1.7 variant on neutralizing monoclonal antibodies recognizing diverse epitopes on SARS-CoV-2 SpikeCarl Graham, Jeffrey Seow, Isabella Huettner, et al.
Immunity|April 9, 2021
Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variantCarl Graham, Jeffrey Seow, Isabella Huettner, et al.
Plos Pathogens|September 24, 2020
Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settingsSuzanne Pickering, Gilberto Betancor, Rui Pedro Galão, et al.
The Journal of Infection|October 17, 2020
Estimates of the rate of infection and asymptomatic COVID-19 disease in a population sample from SE EnglandPhilippa M Wells, Katie J Doores, Simon Couvreur, et al.
Biology Methods & Protocols|July 12, 2024
KCL TEST: an open-source inspired asymptomatic SARS-CoV-2 surveillance programme in an academic institutionJoana Reis de Andrade, Edward Scourfield, Shilpa Lekhraj Peswani-Sajnani, et al.
Nature Microbiology|October 27, 2020
Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humansJeffrey Seow, Carl Graham, Blair Merrick, et al.
Pageof 8